Deceptive imprinting and immune refocusing in vaccine design

被引:85
作者
Tobin, Gregory J. [1 ]
Trujillo, Jessie D. [2 ]
Bushnell, Ruth V. [1 ]
Lin, George [1 ,3 ]
Chaudhuri, A. Ray [1 ]
Long, Jinxue [1 ]
Barrerad, Jose [4 ]
Pena, Lindomar [4 ]
Grubman, Marvin J. [4 ]
Nara, Peter L. [1 ,5 ,6 ]
机构
[1] Biol Mimet Inc, Frederick, MD 21702 USA
[2] Utah State Univ, Utah Vet Diagnost Lab, Logan, UT 84322 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] ARS, USDA, Plum Isl Anim Dis Ctr, Washington, DC USA
[5] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA USA
[6] Iowa State Univ, Coll Vet Med, Ctr Adv Host Def Immunobiot & Translat Med, Ames, IA USA
关键词
Immune refocusing; Deceptive imprinting; Vaccine design;
D O I
10.1016/j.vaccine.2008.09.080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A large number of the world's most widespread and problematic pathogens evade host immune responses by inducing strain-specific immunity to immunodominant epitopes with high mutation rates capable of altering antigenic profiles. The immune system appears to be decoyed into reacting to these immunodominant epitopes that offer little cross protection between serotypes or subtypes. For example, during HIV-1 infection, the immune system reacts strongly to the V1, V2, and/or V3 loops of the Surface envelope glycoprotein but not to epitopes that afford broad protection against strain variants. Similarly, the host mounts strain-specific immunity to immunodominant epitopes of the influenza hemagglutinin (HA) protein. A large number of pathogens appear to exploit this weakness in the host immune system by focusing antigenic attention upon highly variable epitopes while avoiding surveillance toward more highly conserved receptor binding sites or other essential functional domains. Because the propensity of the immune system to react against immunodominant strain-specific epitopes appears to be genetically hard-wired, the phenomenon has been termed "deceptive imprinting." In this review, the authors describe observations related to deceptive imprinting in multiple systems and propose strategies for overcoming this phenomenon in the design of vaccines capable of inducing protection against highly variable pathogens. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6189 / 6199
页数:11
相关论文
共 66 条
[1]   NEUTRALIZATION EPITOPES OF HUMAN RHINOVIRUS TYPE-2 [J].
APPLEYARD, G ;
RUSSELL, SM ;
CLARKE, BE ;
SPELLER, SA ;
TROWBRIDGE, M ;
VADOLAS, J .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :1275-1282
[2]   RECOMBINANT HUMAN FAB FRAGMENTS NEUTRALIZE HUMAN TYPE-1 IMMUNODEFICIENCY VIRUS INVITRO [J].
BARBAS, CF ;
BJORLING, E ;
CHIODI, F ;
DUNLOP, N ;
CABABA, D ;
JONES, TM ;
ZEBEDEE, SL ;
PERSSON, MAA ;
NARA, PL ;
NORRBY, E ;
BURTON, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9339-9343
[3]  
Barouch Dan H, 2007, AIDS Clin Care, V19, P93
[4]   Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor [J].
Bianchi, E ;
Liang, XP ;
Ingallinella, P ;
Finotto, M ;
Chastain, MA ;
Fan, J ;
Fu, TM ;
Song, HC ;
Horton, MS ;
Freed, DC ;
Manger, W ;
Wen, E ;
Shi, L ;
Ionescu, R ;
Price, C ;
Wenger, M ;
Emini, EA ;
Cortese, R ;
Ciliberto, G ;
Shiver, JW ;
Pessi, A .
JOURNAL OF VIROLOGY, 2005, 79 (12) :7380-7388
[5]   ANTIGENIC DRIFT IN INFLUENZA VIRUS-H3 HEMAGGLUTININ FROM 1968 TO 1980 - MULTIPLE EVOLUTIONARY PATHWAYS AND SEQUENTIAL AMINO-ACID CHANGES AT KEY ANTIGENIC SITES [J].
BOTH, GW ;
SLEIGH, MJ ;
COX, NJ ;
KENDAL, AP .
JOURNAL OF VIROLOGY, 1983, 48 (01) :52-60
[6]   Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy [J].
Böttcher, C ;
Ludwig, K ;
Herrmann, A ;
van Heel, M ;
Stark, H .
FEBS LETTERS, 1999, 463 (03) :255-259
[7]   New developments in the epidemiology and clinical spectrum of rhinovirus infections [J].
Brownlee, Joshua W. ;
Turner, Ronald B. .
CURRENT OPINION IN PEDIATRICS, 2008, 20 (01) :67-71
[8]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[9]   THE ANTIGENIC STRUCTURE OF THE INFLUENZA-VIRUS A/PR/8/34 HEMAGGLUTININ (H-1 SUBTYPE) [J].
CATON, AJ ;
BROWNLEE, GG ;
YEWDELL, JW ;
GERHARD, W .
CELL, 1982, 31 (02) :417-427
[10]  
*CDC, 2008, MMWR-MORBID MORTAL W, V57, P393